Efficacy and safety evaluation of pregabalin treatment over 52 weeks in patients with diabetic neuropathic pain extended after a double blind placebo controlled trial
Aims/Introduction: Diabetic peripheral neuropathy (DPN) is often associated with pain, and thus a new treatment option is anticipated. We recently showed the efficacy of pregabalin in a randomized, double blind, placebo controlled, 14 week trial in Japanese patients with painful DPN. In the present study, we evaluated the long term efficacy and safety of pregabalin for the relief of painful DPN.
Journal of diabetes investigation